BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/2/2014 3:20:00 PM | Browse: 1308 | Download: 1343
 |
Received |
|
2013-09-25 10:29 |
 |
Peer-Review Started |
|
2013-09-25 16:21 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-11-22 08:56 |
 |
Revised |
|
2013-12-03 18:58 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-01-15 20:20 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-01-15 20:36 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-02-19 11:58 |
 |
Publish the Manuscript Online |
|
2014-02-26 11:18 |
| Category |
Oncology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Telomeres, telomerase and colorectal cancer
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Roberta Bertorelle, Enrica Rampazzo, Salvatore Pucciarelli, Donato Nitti and Anita De Rossi |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Anita De Rossi, PhD, Department of Surgery, Oncology and Gastroenterology, Section of Oncology and Immunology, University of Padova, IOV-IRCCS, Via Gattamelata 64, 35128 Padova, Italy. anita.derossi@unipd.it |
| Key Words |
Telomere; Telomerase; Telomerase reverse transcriptase; Colorectal cancer; Prognostic marker |
| Core Tip |
Telomere/telomerase interplay is an important mechanism involved in both genomic stability and cellular replicative potential. Telomere shortening is an early event that contributes to genetic instability, which plays a key role in the early steps of carcinogenesis. The activation of telomerase, which preserves replicative potential by maintaining the length of telomeres, occurs during the adenoma-carcinoma sequence and increases during tumour progression. While the prognostic value of telomere length is controversial, most studies agree that the level of telomerase in tumours represents a useful prognostic marker. Circulating telomerase reverse transcriptase is a promising marker for the minimally invasive monitoring of disease and response to therapy.
|
| Publish Date |
2014-02-26 11:18 |
| Citation |
Bertorelle R, Rampazzo E, Pucciarelli S, Nitti D, De Rossi A. Telomeres, telomerase and colorectal cancer. World J Gastroenterol 2014; 20(8): 1940-1950 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i8/1940.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i8.1940 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.